Christopher R. Fenimore

Companies

• Regeneron PharmaceuticalsChief financial officer Feb 12, 2024 to now¹
• Regeneron PharmaceuticalsVP, Controller Mar 2, 2017 to Jan 25, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Regeneron Pharmaceuticals REGN20,009 shares³$16.1M at $806.51Aug 20, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 18, 2026Shares withheld for tax 4,599 shares at $813.47 of Regeneron Pharmaceuticals³
• Aug 18, 2026Exercised options 6,283 shares at $381.92 of Regeneron Pharmaceuticals³
• Dec 8, 2025Shares withheld for tax 992 shares at $712.94 of Regeneron Pharmaceuticals⁴
• Dec 5, 2025Granted 3,027 shares of Regeneron Pharmaceuticals⁴
• Dec 16, 2024Shares withheld for tax 491 shares at $730.81 of Regeneron Pharmaceuticals⁵
• Dec 9, 2024Shares withheld for tax 1,140 shares at $787.00 of Regeneron Pharmaceuticals⁶
• Dec 6, 2024Granted 2,591 shares of Regeneron Pharmaceuticals⁶
• Aug 28, 2024Sold 200 shares at $1,206.67 of Regeneron Pharmaceuticals⁷
• Aug 28, 2024Sold 235 shares at $1,205.67 of Regeneron Pharmaceuticals⁷
• Aug 28, 2024Sold 200 shares at $1,206.70 of Regeneron Pharmaceuticals⁷
• Aug 28, 2024Sold 236 shares at $1,205.67 of Regeneron Pharmaceuticals⁷
• Aug 28, 2024Sold 450 shares at $1,206.15 of Regeneron Pharmaceuticals⁷
• Aug 28, 2024Sold 928 shares at $1,205.49 of Regeneron Pharmaceuticals⁷
• Aug 28, 2024Sold 2,237 shares at $1,204.71 of Regeneron Pharmaceuticals⁷
• Aug 28, 2024Sold 200 shares at $1,206.30 of Regeneron Pharmaceuticals⁷
• Aug 28, 2024Sold 766 shares at $1,205.44 of Regeneron Pharmaceuticals⁷
• Aug 28, 2024Sold 228 shares at $1,204.79 of Regeneron Pharmaceuticals⁷
• Feb 9, 2024Sold 600 shares at $955.00 of Regeneron Pharmaceuticals⁸
• Feb 9, 2024Sold 1,100 shares at $954.57 of Regeneron Pharmaceuticals⁸
• Feb 9, 2024Sold 1,342 shares at $953.47 of Regeneron Pharmaceuticals⁸
• Feb 9, 2024Sold 1,046 shares at $952.62 of Regeneron Pharmaceuticals⁸
• Feb 9, 2024Sold 487 shares at $951.39 of Regeneron Pharmaceuticals⁸
• Feb 9, 2024Sold 344 shares at $950.49 of Regeneron Pharmaceuticals⁸
• Jan 23, 2024Shares withheld for tax 3,583 shares at $948.50 of Regeneron Pharmaceuticals⁹
• Jan 23, 2024Exercised options 5,000 shares at $399.66 of Regeneron Pharmaceuticals⁹